News from NORD

NORD Awards Grants for Rare Disease Research


 

The National Organization for Rare Disorders (NORD) has awarded seven new research grants to fund rare disease research. These grants are in response to NORD’s 2016 Requests for Proposals. The 2017 Requests for Proposals will be published soon on the NORD website , where funding opportunities from NORD member organizations also are posted.

The new grant recipients are:

For the study of Alveolar Capillary Dysplasia with Misalignment of the Pulmonary Veins (ACD/MPV), with support funding raised by the David Ashwell Foundation and the Alveolar Capillary Dysplasia Association

  • Przemyslaw Szafranski PhD, Baylor College of Medicine

For the study of Appendix Cancer and Pseudomyxoma Peritonei (PMP), with support funding raised by the Appendix Cancer Pseudomyxoma Peritonei Research Foundation

  • Venkatesh Govindarajan PhD, Creighton University
  • David L. Morris MD PhD, St. George Hospital, Australia

For the study of Autoimmune Polyglandular Syndrome Type 1 (APS Type 1), with support funding raised by the APS Type 1 Foundation

  • Maureen A. Su MD, University of North Carolina at Chapel Hill

For the study of Homocystinuria due to Cystathionine Beta-Synthase Deficiency, with support funding raised from public donations

  • Warren D. Kruger PhD, The Research Institute of Fox Chase Cancer Center

For the study of Malonic Aciduria, with support funding raised by the Hope Fund, Lundbeck “Raise Your Hand” campaign, and public donations

  • Michael J. Wolfgang PhD, Johns Hopkins University School of Medicine

For the study of Stiff Person Syndrome, with support funding raised by the Lundbeck “Raise Your Hand” campaign and public donations

  • Sarah Crisp PhD, University College, London

Grants are made possible by donations to NORD research funds and the assistance of rare disease medical experts who serve on NORD’s Medical Advisory Committee.

Recommended Reading

Aplastic Anemia & MDS International Foundation Research Portal Is Open
MDedge Dermatology
APS Type 1 Symposium Is Planned
MDedge Dermatology
Foundation for Prader-Willi Research Highlights Study of Genetic Therapy for Prader-Willi Syndrome
MDedge Dermatology
Comparison of immunosuppressants for early diffuse systemic sclerosis yields mixed results
MDedge Dermatology
Lanadelumab reduced hereditary angioedema attacks by 88%-100%
MDedge Dermatology
Pediatric lupus patients face large burden of serious infection
MDedge Dermatology
Large, intermittent vitamin D doses may increase fracture, fall risk in elderly
MDedge Dermatology
Hidradenitis Suppurativa Scoring Systems: Can We Choose Just One?
MDedge Dermatology
Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis
MDedge Dermatology
GAO to launch investigation of FDA’s Orphan Drug program
MDedge Dermatology